Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8 von Larson, Peter, Kucaba, Tamara A, Xiong, Zhengming, Olin, Michael, Griffith, Thomas S, Ferguson, David M

Volltext

Topical Imiquimod has Therapeutic and Immunomodulatory Effects Against Intracranial Tumors von ZHENGMING XIONG, OHLFEST, John R

Volltext

213 Use of A novel peptide ligand targeting multiple immune checkpoints: a novel approach to immunotherapy against central nervous system tumors von Moertel, Christopher, Xiong, Zhengming, Olin, Michael

Volltext

Superior Efficacy of Tumor Cell Vaccines Grown In Physiologic Oxygen von OLIN, Michael R, ANDERSEN, Brian M, BLAZAR, Bruce R, OHLFEST, John R, ZELLMER, David M, GROGAN, Patrick T, POPESCU, Flavia E, ZHENGMING XIONG, FORSTER, Colleen L, SEILER, Charlie, SANTACRUZ, Karen S, WEI CHEN

Volltext

Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis von ZHENGMING XIONG, GHARAGOZLOU, Soheila, VENGCO, Isabelita, WEI CHEN, OHLFESTL, John R

Volltext

IMMU-10. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS von Moertel, Christopher, Xiong, Zhengming, Pluhar, G-Elisabeth, Olin, Michael

Volltext

In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene von Niu, Gang, Xiong, Zhengming, Cheng, Zhen, Cai, Weibo, Gambhir, Sanjiv S, Xing, Lei, Chen, Xiaoyuan

Volltext

Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3 Expression in Living Mice von Cheng, Zhen, Wu, Yun, Xiong, Zhengming, Gambhir, Sanjiv Sam, Chen, Xiaoyuan

Volltext

ATIM-34. TARGETING THE CD200 CHECKPOINT FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS von Olin, Michael, Xiong, Zhengming, Pluhar, Elisabeth, Moertel, and Christopher

Volltext

CTIM-31. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS von Moertel, Christopher, Xiong, Zhengming, Zellmer, David, Pluhar, Elizabeth, Neil, Elizabeth, Greengard, Emely, Olin, Michael

Volltext

CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy von Xiong, Zhengming, Ampudia Mesias, Elisabet, Pluhar, G Elizabeth, Rathe, Susan K, Largaespada, David A, Sham, Yuk Y, Moertel, Christopher L, Olin, Michael R

Volltext

IMMU-03. TARGETING THE CD200 CHECKPOINT BLOCKADE FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS von Pluhar, Elisabeth, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Moertel, Christopher, Olin, Michael

Volltext

Structure–Activity Relationship Analysis of Imidazoquinolines with Toll-like Receptors 7 and 8 Selectivity and Enhanced Cytokine Induction von Schiaffo, Charles E., Shi, Ce, Xiong, Zhengming, Olin, Michael, Ohlfest, John R., Aldrich, Courtney C., Ferguson, David M.

Volltext

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice von Pennell, Christopher A., Barnum, Jessie L., McDonald-Hyman, Cameron S., Panoskaltsis-Mortari, Angela, Riddle, Megan J., Xiong, Zhengming, Loschi, Michael, Thangavelu, Govindarajan, Campbell, Heather M., Storlie, Meghan D., Refaeli, Yosef, Furlan, Scott N., Jensen, Michael C., Kean, Leslie S., Miller, Jeffrey S., Tolar, Jakub, Osborn, Mark J., Blazar, Bruce R.

Volltext

IMMU-11. TARGETING THE CD200 CHECKPOINT BLOCKADE: A NEW DIRECTION FOR IMMUNOTHERAPY von Olin, Michael, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pluhar, Elizabeth, Moertel, Christopher

Volltext

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma von Yang, Yi-Shan, Zhang, Xianzhong, Xiong, Zhengming, Chen, Xiaoyuan

Volltext

Near-Infrared Fluorescent Deoxyglucose Analogue for Tumor Optical Imaging in Cell Culture and Living Mice von Cheng, Zhen, Levi, Jelena, Xiong, Zhengming, Gheysens, Olivier, Keren, Shay, Chen, Xiaoyuan, Gambhir, Sanjiv Sam

Volltext

IMMU-23. TARGETING THE CD200 CHECKPOINT TO ENHANCE IMMUNOTHERAPY FOR CNS TUMORS von Moertel, Christopher, Pluhar, G Elizabeth, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pennell, Christopher A, Rathe, Susan K, Largaespada, David A, Olin, Michael R

Volltext

CADD-14. TARGETING THE CD200 CHECKPOINT FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS von Olin, Michael, Ampudia-Mesias, Elisabet, Pennell, Christopher A, Xiong, Zhengming, Rathe, Susan K, Largaespada, David A, Moertel, Christopher L, Pluhar, G Elizabeth

Volltext

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy von Xiong, Zhengming, Ampudia-Mesias, Elisabet, Shaver, Rob, Horbinski, Craig M, Moertel, Christopher L, Olin, Michael R

Volltext